Maria L. Ascierto, Ph.D. Saint John's Cancer Institute

Saint John's Cancer Institute's Director of Translational Immunology, Maria L. Ascierto, Ph.D. Contact Dr. Ascierto via email or phone number.

Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases

33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

Maria Libera Ascierto on LinkedIn: cells-11-03147.pdf

Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1–Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial - Journal of Thoracic Oncology

Antoni Ribas – UCLA Graduate Programs in Bioscience (GPB)

Joanne Weidhaas – UCLA Graduate Programs in Bioscience (GPB)

Melanoma and Cutaneous Oncology - Saint John's Cancer Institute

(PDF) Immune evasion in cancer: Mechanistic basis and therapeutic strategies

Rosalie and Harold Rae Brown Cancer Immunotherapy Research Program

Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy), Journal of Translational Medicine

Cabrini Research Annual Report 2020-21 by Cabrini Health - Issuu